Short interest for healthcare stocks in S&P 500 increased during September end vs. last month, with Moderna being most ...

AbbVie has been reporting an earnings decline because its former lead drug, Humira, lost patent-protected market exclusivity ...

UBS Global Research on Tuesday raised its year-end target for the benchmark S&P 500 index to 5,850 points from an earlier ...

The S&P 500’s information-technology sector was dropping sharply heading toward the closing bell on Tuesday, dragging down ...

The S&P 500 advanced 0.8% on Monday, adding to the benchmark index's all-time high Friday for a second straight record close.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

The S&P 500 opened today at 5,698.14. Within 30 minutes of trading, the benchmark index fell by 4.64 points, or 0.08%, to ...

Most of the S&P 500 was holding up well on Tuesday, but chip stocks were dragging the index down in the wake of ASML Holdings’ surprise earnings report. The market benchmark was down 0.4%, but 351 of ...

The U.S. stock market was broadly rallying Monday afternoon, with almost all sectors in the S&P 500 index trading up. The S&P 500, a gauge of U.S. large-cap stocks, was rising 0.7%, putting it on pace ...

The S&P 500 finished the week ending October 11 with another record-breaking rally, up 0.97% from last Friday.

But for many investors, S&P 500 index funds remain the overwhelming favorite when it comes to long-term investing. The S&P 500 index tracks the prices of the 500 largest U.S. public companies ...

Until three years ago, the S&P 500 Index, which comprises the largest companies in the US, was the province of expert ...